Clinical Pharmacology and Drug Toxicity Practice Questions

Q: All of the following drugs are documented to be porphyrinogenic EXCEPT:

Aspirin. **Explanation:**The primary mechanism behind drug-induced porphyria (specifically Acute Intermittent Porphyria) is the **induction of the enzyme ALA synthase**. This enzyme is the rate-limiting step in heme synthesis. When certain drugs stimulate the Cytochrome P450 (CYP450) system, they increase the demand for heme [1], which in turn relieves the negative feedback on ALA synthase, leading to the toxic accumulation of porphyrin precursors.**Why Aspirin is the Correct Answer:**Aspirin (Salicylates) is considered **non-porphyrinogenic** and is listed as a safe drug in patients with porphyria. It does not significantly induce the CYP450 system or ALA synthase, making it a safe analgesic choice for these patients. [2]**Why the other options are Porphyrinogenic:*** **Estrogen therapy:** Steroid hormones, including estrogens and oral contraceptives, are potent triggers for acute porphyric attacks. [1]* **Carbamazepine & Phenytoin:** Both are classic **enzyme inducers**. By inducing the hepatic CYP450 system, they rapidly deplete the regulatory heme pool, triggering a massive up-regulation of ALA synthase.**High-Yield Clinical Pearls for NEET-PG:*** **Common Porphyrinogenic Drugs (The "P"s):** **P**henobarbitone (and other Barbiturates), **P**henytoin, **P**yrazinamide, **P**rogesterone, and Griseofulvin.* **Safe Drugs in Porphyria:** Aspirin, Paracetamol, Morphine, Penicillin, and Atropine. [2]* **Clinical Presentation:** Patients typically present with the "5 Ps": **P**ainful abdomen, **P**olyneuropathy, **P**sychological disturbances, **P**ink urine, and **P**recipitated by drugs.* **Treatment of Choice:** Intravenous **Hematin** (Heme arginate) or Glucose loading, both of which inhibit ALA synthase via negative feedback.

Q: Which of the following is NOT a feature of acute cholinesterase inhibitor intoxication?

Mydriasis. **Explanation:** Acute cholinesterase inhibitor intoxication (e.g., Organophosphate or Carbamate poisoning) leads to an accumulation of excessive Acetylcholine (ACh) at both muscarinic and nicotinic receptors. This results in a state of "cholinergic crisis." **1. Why Mydriasis is the correct answer:** Acetylcholine stimulates the **M3 receptors** on the circular muscles (sphincter pupillae) of the iris, leading to pupillary constriction, known as **Miosis** (pinpoint pupils). **Mydriasis** (pupillary dilation) is a sympathetic/anticholinergic effect and is therefore NOT a feature of cholinergic toxicity. **2. Why the other options are incorrect:** The symptoms of organophosphate poisoning are best remembered by the mnemonic **DUMBELS**: * **Salivation and Sweating (Option A):** ACh stimulates M3 receptors in exocrine glands, causing profuse sweating (diaphoresis) and salivation. * **Bronchoconstriction (Option C):** Stimulation of M3 receptors in the bronchial smooth muscle leads to bronchospasm and increased bronchial secretions. * **Vomiting and Diarrhea (Option D):** ACh increases gastrointestinal motility and relaxes sphincters (via M3), leading to nausea, vomiting, abdominal cramps, and diarrhea. **Clinical Pearls for NEET-PG:** * **Management:** The specific antidote is **Atropine** (reverses muscarinic effects). **Pralidoxime (2-PAM)** is used as a cholinesterase regenerator but must be given before "aging" of the enzyme occurs. * **Nicotinic Effects:** While muscarinic effects dominate early, nicotinic stimulation can cause muscle fasciculations followed by paralysis. * **Exception:** In rare cases of severe toxicity, sympathetic ganglia stimulation may cause transient tachycardia or mydriasis, but **Miosis** remains the classic diagnostic hallmark.

Q: All of the following drugs can cause cholestatic jaundice EXCEPT:

Isoniazid (INH). ### Explanation The key to answering this question lies in distinguishing between the two main types of drug-induced liver injury (DILI): **Cholestatic** (interference with bile flow) and **Hepatocellular** (direct damage to hepatocytes). **1. Why Isoniazid (INH) is the correct answer:** Isoniazid is a classic cause of **hepatocellular (hepatotoxic) injury**, not cholestatic jaundice. It causes an elevation in serum transaminases (ALT/AST) due to the formation of toxic metabolites (like acetylhydrazine) via the N-acetyltransferase pathway. In severe cases, it can lead to hepatic necrosis resembling viral hepatitis. **2. Analysis of Incorrect Options (Drugs causing Cholestasis):** * **Erythromycin estolate:** This is the most common salt of erythromycin associated with **acute cholestatic hepatitis**. It is often considered a hypersensitivity reaction and is a classic "textbook" cause of cholestasis. * **Oral Contraceptive Pills (OCPs):** Estrogens in OCPs can interfere with the transport of bile salts across the canalicular membrane, leading to **dose-dependent cholestasis** and occasionally "bland cholestasis" without significant inflammation. * **Chlorpromazine:** This antipsychotic is a well-known cause of **cholestatic jaundice** via a hypersensitivity-type reaction, typically occurring within the first few weeks of treatment. **NEET-PG High-Yield Pearls:** * **Hepatocellular Pattern:** INH, Rifampicin, Pyrazinamide, Paracetamol, Halothane, and Sodium Valproate. * **Cholestatic Pattern:** Anabolic steroids, Methyltestosterone, Chlorpromazine, Erythromycin estolate, and OCPs. * **Mixed Pattern:** Phenytoin, Carbamazepine. * **Note:** Among Anti-TB drugs, **Pyrazinamide** is the most hepatotoxic, while **Ethambutol** is the least (usually considered non-hepatotoxic).

Q: Which of the following drugs is useful in the treatment of Malathion poisoning?

Pralidoxime. **Explanation:** **Malathion** is an **Organophosphate (OP) compound**, which acts by irreversibly inhibiting the enzyme Acetylcholinesterase (AChE). This leads to an accumulation of Acetylcholine (ACh) at muscarinic and nicotinic receptors, causing a "cholinergic crisis." **Why Pralidoxime is correct:** Pralidoxime (2-PAM) is a **Cholinesterase Reactivator**. It works by cleaving the phosphate group from the anionic site of the inhibited AChE enzyme, thereby restoring its activity. It is specifically effective against the **nicotinic effects** (like muscle fasciculations and paralysis). It must be administered early, before "aging" of the enzyme-toxin bond occurs. **Why other options are incorrect:** * **Rivastigmine:** This is a carbamate-type reversible AChE inhibitor used in Alzheimer’s disease. Administering it would worsen the cholinergic crisis by further inhibiting the enzyme. * **Atropine:** While Atropine is a crucial part of the treatment for OP poisoning, it only antagonizes **muscarinic** effects (bradycardia, secretions). It does not reactivate the enzyme or treat nicotinic toxicity. *Note: In many clinical scenarios, both are used, but Pralidoxime is the specific antidote for the enzyme inhibition itself.* * **d-Tubocurarine:** This is a skeletal muscle relaxant (competitive nicotinic antagonist). It is contraindicated as it can exacerbate respiratory failure in the context of OP poisoning. **High-Yield Clinical Pearls for NEET-PG:** * **Atropinization:** The goal of treatment is to dry up secretions (monitored by clearing of lung crepitations). * **Aging:** Once the OP-enzyme complex "ages," oximes become ineffective. * **Differentiating Carbamate vs. OP poisoning:** Oximes (Pralidoxime) are generally **avoided in Carbaryl (carbamate) poisoning** because the enzyme-carbamate bond is reversible and oximes may worsen the toxicity.

Q: Hyperkalemia is not caused by which of the following medications?

Salbutamol. ### Explanation The correct answer is **Salbutamol**. **1. Why Salbutamol is the correct answer:** Salbutamol is a **$\beta_2$-adrenergic agonist**. Stimulation of $\beta_2$ receptors activates the Na⁺/K⁺-ATPase pump, which shifts potassium from the extracellular fluid into the intracellular compartment (primarily into skeletal muscle). This results in **hypokalemia**, not hyperkalemia. Due to this mechanism, nebulized salbutamol is clinically used as an emergency treatment to lower serum potassium levels in patients with hyperkalemia. **2. Why the other options are incorrect:** * **ACE Inhibitors (e.g., Enalapril):** These drugs inhibit the synthesis of Angiotensin II, leading to decreased secretion of **Aldosterone**. Since aldosterone is responsible for potassium excretion in the distal tubule, its deficiency leads to potassium retention (**Hyperkalemia**). * **Cyclosporine:** This calcineurin inhibitor causes **Hyperkalemia** by suppressing aldosterone synthesis and inducing tubular resistance to aldosterone. It also interferes with the ROMK (Renal Outer Medullary Potassium) channels. * **GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor):** A less common but high-yield fact is that GM-CSF can cause **Hyperkalemia** as a side effect, often associated with rapid cell turnover or lysis (Tumor Lysis Syndrome-like effect) or renal effects. **3. NEET-PG High-Yield Pearls:** * **Drugs causing Hyperkalemia (K-BANK):** **K**-sparing diuretics (Spironolactone), **B**eta-blockers (non-selective), **A**CE inhibitors/ARBs, **N**SAIDs, and **K**-supplementation/Heparin/Cyclosporine. * **Drugs causing Hypokalemia:** $\beta_2$ agonists, Insulin, Diuretics (Thiazides/Loop), and Amphotericin B. * **Management of Hyperkalemia:** "C BIG K" — **C**alcium gluconate (cardioprotection), **B**icarbonate/ **B**eta-agonists, **I**nsulin + **G**lucose, **K**ayexalate (Resins), and Dialysis.

Q: Methemoglobinemia is a known complication following the administration of which of the following drugs?

Prilocaine. **Explanation:** **Prilocaine** is the correct answer because of its unique metabolic pathway. It is an amide-linked local anesthetic that is metabolized in the liver into **o-toluidine**. This specific metabolite is an oxidizing agent that converts ferrous iron ($Fe^{2+}$) in hemoglobin to ferric iron ($Fe^{3+}$), resulting in the formation of **methemoglobin**. Methemoglobin cannot effectively bind or transport oxygen, leading to tissue hypoxia and characteristic "chocolate-colored blood" or cyanosis that does not improve with oxygen therapy. **Analysis of Options:** * **Lignocaine & Lidocaine (Options A & B):** These are the same drug. While lidocaine is the most commonly used local anesthetic, it does not typically cause methemoglobinemia at standard doses. (Note: In rare cases of extreme toxicity, its metabolite *monoethylglycinexylidide* might contribute, but it is not the classic association). * **Procaine (Option D):** This is an ester-linked local anesthetic. It is rapidly hydrolyzed by plasma pseudocholinesterase into para-aminobenzoic acid (PABA), which is associated with allergic reactions rather than methemoglobinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Other causative agents:** Benzocaine (topical spray), Nitrites/Nitrates, Dapsone, and Sulfonamides. * **Clinical Presentation:** Cyanosis with a "normal" $PaO_2$ on ABG but low $SpO_2$ (the "Saturation Gap"). * **Treatment of Choice:** **Methylene Blue** (1-2 mg/kg IV). It acts as a reducing agent to restore iron to its $Fe^{2+}$ state. * **Alternative Treatment:** Vitamin C (Ascorbic acid) can be used if Methylene Blue is contraindicated (e.g., in G6PD deficiency).

Q: Hypertension is not seen with which of the following agents?

L-dopa. The correct answer is **L-dopa**. **1. Why L-dopa is the correct answer:** L-dopa (Levodopa) is the precursor of dopamine used in Parkinson’s disease. While it can occasionally cause hypertension if combined with MAO inhibitors (hypertensive crisis), its primary cardiovascular side effect is **orthostatic (postural) hypotension**. This occurs because peripheral decarboxylation of L-dopa leads to increased dopamine, which acts on vascular dopamine receptors (D1) causing vasodilation, and can also interfere with sympathetic ganglionic transmission [1]. **2. Analysis of Incorrect Options:** * **SNRIs (e.g., Venlafaxine):** These inhibit the reuptake of both Serotonin and Norepinephrine [2]. Increased synaptic norepinephrine levels lead to alpha and beta-adrenergic stimulation, resulting in dose-dependent increases in blood pressure. * **Amphetamines:** These are indirect sympathomimetics that displace norepinephrine from storage vesicles into the synapse [1]. This leads to potent vasoconstriction and increased cardiac output, consistently causing hypertension. * **Erythropoietin (EPO):** Hypertension is a well-known side effect of EPO therapy (seen in ~20-30% of patients), particularly in those with chronic kidney disease. It is thought to be caused by an increase in whole-blood viscosity and the reversal of hypoxic vasodilation. **3. NEET-PG High-Yield Pearls:** * **Drug-Induced Hypertension:** Common culprits include NSAIDs, Oral Contraceptive Pills (OCPs), Steroids, Cyclosporine, and Sympathomimetics. * **L-dopa Side Effects:** Remember the mnemonic **"DOPAMINE"**: **D**yskinesias, **O**rthostatic hypotension, **P**sychosis, **A**norexia, **M**idriasis (rare), **I**nsomnia, **N**ausea, **E**nd-of-dose akinesia. * **Clinical Tip:** To minimize the peripheral side effects of L-dopa (like hypotension and nausea), it is always co-administered with a peripheral decarboxylase inhibitor like **Carbidopa** [3].

Q: Predictable and dose-related drug-induced hepatic injury is seen with all of the following EXCEPT:

Isoniazid (INH). Drug-induced liver injury (DILI) is classified into two main types: **Predictable (Intrinsic)** and **Unpredictable (Idiosyncratic).** [1] **1. Why Isoniazid (INH) is the correct answer:** Isoniazid causes **Idiosyncratic (Unpredictable)** hepatotoxicity. This type of injury is not dose-related, has a variable latency period, and cannot be reproduced in animal models. It occurs in a small percentage of patients (approx. 1%) due to individual metabolic variations (e.g., acetylator status) or immune responses [2]. Because it is not dose-dependent, it is the "Except" in this list. **2. Analysis of Incorrect Options (Predictable Hepatotoxins):** * **Acetaminophen (Paracetamol):** The classic example of dose-related toxicity. At high doses, the glutathione pathway is saturated, leading to the accumulation of the toxic metabolite **NAPQI**, causing centrilobular necrosis [3]. * **Carbon Tetrachloride ($CCl_4$):** A potent direct hepatotoxin. It undergoes metabolism to the free radical $CCl_3\cdot$, causing lipid peroxidation and predictable, dose-dependent liver cell death. * **Oral Contraceptive Agents:** These cause predictable, dose-related **cholestasis** (interference with bile excretion) rather than necrosis, but the effect is still considered intrinsic to the drug's pharmacological action on the canalicular membrane. **NEET-PG High-Yield Pearls:** * **Most common cause of DILI (Global):** Acetaminophen [3]. * **Most common cause of Idiosyncratic DILI:** Amoxicillin-Clavulanate. * **INH Monitoring:** Asymptomatic rise in transaminases (up to 3x normal) occurs in 10-20% of patients; the drug is usually continued unless levels exceed 5x normal or the patient becomes symptomatic. * **Halothane:** Another classic example of idiosyncratic (Type II) hepatotoxicity.

Question 1

All of the following drugs are documented to be porphyrinogenic EXCEPT:

Accepted Answer

Aspirin

Answer

Estrogen therapy

Answer

Carbamazepine

Answer

Phenytoin

Question 2

Which of the following is NOT a feature of acute cholinesterase inhibitor intoxication?

Accepted Answer

Mydriasis

Answer

Salivation and sweating

Answer

Bronchoconstriction

Answer

Vomiting and diarrhea

Question 3

A 34-year-old man is brought to the emergency room by his family because of extreme lethargy. After further questioning, he admits to taking a large number of phenobarbital tablets. Which of the following is the most appropriate next step in management?

Accepted Answer

Repetitive administration of activated charcoal

Answer

Acidification of urine to pH 3.0

Answer

Ipecac to induce vomiting

Answer

Hemoperfusion

Question 4

All of the following drugs can cause cholestatic jaundice EXCEPT:

Accepted Answer

Isoniazid (INH)

Answer

Erythromycin estolate

Answer

Oral contraceptive pills

Answer

Chlorpromazine

Question 5

Which of the following drugs is useful in the treatment of Malathion poisoning?

Accepted Answer

Pralidoxime

Answer

Rivastigmine

Answer

Atropine

Answer

d-Tubicuranine

Question 6

A 60-year-old female presented with left jaw pain and fever. Examination revealed poor dentition, a purulent drainage area in the mouth, right-sided facial swelling, and diffuse mandibular tenderness. Her medication history includes alendronate and lisinopril. Microscopic examination of purulent secretions was performed. What is the most appropriate drug for this condition?

Accepted Answer

Penicillin

Answer

Azithromycin

Answer

Griseofulvin

Answer

Metronidazole

Question 7

Hyperkalemia is not caused by which of the following medications?

Accepted Answer

Salbutamol

Answer

ACE Inhibitors

Answer

Cyclosporine

Answer

GM-CSF

Question 8

Methemoglobinemia is a known complication following the administration of which of the following drugs?

Accepted Answer

Prilocaine

Answer

Lignocaine

Answer

Lidocaine

Answer

Procaine

Question 9

Hypertension is not seen with which of the following agents?

Accepted Answer

L-dopa

Answer

SNRIs

Answer

Amphetamine

Answer

Erythropoietin

Question 10

Predictable and dose-related drug-induced hepatic injury is seen with all of the following EXCEPT:

Accepted Answer

Isoniazid (INH)

Answer

Carbon tetrachloride

Answer

Acetaminophen

Answer

Oral contraceptive agent

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?